ストックスクリーナーアプリを入手
1.385
4.48%
-0.065
プレマーケット:
1.45
0.065
+4.69%
前日終値:
$1.45
開ける：
$1.47
24時間の取引高:
247.96K
Relative Volume:
1.33
時価総額：
$69.45M
収益：
-
当期純損益:
$-123.57M
株価収益率:
-0.4556
EPS:
-3.04
ネットキャッシュフロー:
$-97.53M
1週間 パフォーマンス:
-15.55%
1か月 パフォーマンス:
-22.63%
6か月 パフォーマンス:
-22.19%
1年 パフォーマンス:
-91.31%
1日の値動き範囲:
$1.37
$1.47
1週間の範囲:
$1.37
$1.71
52週間の値動き範囲:
$1.37
$16.30
Hillevax Inc Stock (HLVX) Company Profile
HLVX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HLVX
Hillevax Inc
|
1.385 | 69.45M | 0 | -123.57M | -97.53M | -3.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.74 | 124.48B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
617.00 | 67.45B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
567.09 | 34.59B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
255.76 | 33.10B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
271.04 | 29.15B | 3.81B | -644.79M | -669.77M | -6.24 |
Hillevax Inc Stock (HLVX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-09 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2024-07-09 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-07-09 | ダウングレード | Stifel | Buy → Hold |
| 2024-07-08 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-07-08 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2023-12-13 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Hillevax Inc (HLVX) 最新ニュース
HilleVax (NASDAQ:HLVX) Given Neutral Rating at HC Wainwright - Defense World
Cautious Hold Rating on HilleVax Amid Norovirus Vaccine Development Setbacks - TipRanks
HilleVax Reports 2024 Financial Results Amid Strategic Exploration - MSN
HilleVax Inc. (HLVX) reports earnings - Quartz
HilleVax, Inc. SEC 10-K Report - TradingView
HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress - The Manila Times
Shareholder Rights Advocates at Levi & Korsinsky Investigate HilleVax, Inc. (HLVX) Regarding Possible Securities Fraud Violations - ACCESS Newswire
HilleVax (HLVX) to Release Quarterly Earnings on Wednesday - Defense World
HILLEVAX Earnings Preview: Recent $HLVX Insider Trading, Hedge Fund Activity, and More - Nasdaq
HilleVax (NASDAQ:HLVX) & Omega Therapeutics (NASDAQ:OMGA) Critical Survey - Defense World
HKVX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into HilleVax, Inc. and Encourages Investors to Contact the Firm! - ACCESS Newswire
Hillevax CFO Shane Maltbie sells $15,116 in stock By Investing.com - Investing.com Nigeria
Stocks of HilleVax Inc (HLVX) are poised to climb above their peers - SETE News
Hillevax CEO Robert Hershberg sells $48,661 in stock - MSN
HilleVax, Inc. (NASDAQ:HLVX) Shares Purchased by SG Americas Securities LLC - Defense World
Hillevax CFO Shane Maltbie sells $15,116 in stock - MSN
HilleVax, Inc. (NASDAQ:HLVX) Shares Sold by Qiming U.S. Ventures Management LLC - MarketBeat
Top Executives Cash In on HilleVax Stock Sales - TipRanks
HilleVax Executives Sell Shares in February 2025 - TradingView
Vitro Diagnostics (OTCMKTS:VODG) vs. HilleVax (NASDAQ:HLVX) Financial Review - Defense World
HKVX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into HilleVax, Inc. and Encourages Stockholders to Contact the Firm! - ACCESS Newswire
HilleVax, Inc. (NASDAQ:HLVX) Shares Purchased by Barclays PLC - Defense World
Jane Street Group LLC Purchases 35,546 Shares of HilleVax, Inc. (NASDAQ:HLVX) - Defense World
HilleVax, Inc. (NASDAQ:HLVX) Shares Sold by Geode Capital Management LLC - Defense World
Barclays PLC Raises Holdings in HilleVax, Inc. (NASDAQ:HLVX) - Defense World
Critical Comparison: Zura Bio (NASDAQ:ZURA) versus HilleVax (NASDAQ:HLVX) - Defense World
HilleVax, Inc. (NASDAQ:HLVX) Shares Sold by State Street Corp - Defense World
Cancer Vaccine Breaking News - Vax-Before-Travel
Short Interest in HilleVax, Inc. (NASDAQ:HLVX) Expands By 7.4% - MarketBeat
Charles Schwab Investment Management Inc. Has $133,000 Stake in HilleVax, Inc. (NASDAQ:HLVX) - Defense World
Critical Survey: Fate Therapeutics (NASDAQ:FATE) versus HilleVax (NASDAQ:HLVX) - Defense World
Financial Contrast: Vericel (NASDAQ:VCEL) versus HilleVax (NASDAQ:HLVX) - Defense World
HilleVax, Inc. Announces Management Changes - Marketscreener.com
3 US Penny Stocks With Market Caps Under $100M - simplywall.st
HilleVax initiates major workforce reduction, executives depart By Investing.com - Investing.com Australia
HilleVax initiates major workforce reduction, executives depart - Investing.com
HilleVax Shares Rise After Announcing Job Cuts, Executive Departures - MarketWatch
HilleVax, Inc. Announces Workforce Reduction and Leadership Changes - TipRanks
Head to Head Survey: HilleVax (NASDAQ:HLVX) versus NKGen Biotech (NYSE:NKGN) - Defense World
JP Morgan Downgrades HilleVax (HLVX) - MSN
1,064,000 Shares in HilleVax, Inc. (NASDAQ:HLVX) Bought by Braidwell LP - MarketBeat
GSA Capital Partners LLP Acquires New Shares in HilleVax, Inc. (NASDAQ:HLVX) - Defense World
England's Norovirus Outbreak Peaks Early in 2024 - Precision Vaccinations
HilleVax, Inc. (NASDAQ:HLVX) Short Interest Update - MarketBeat
HilleVax (NASDAQ:HLVX) Stock Price Down 1.5% on Disappointing Earnings - Defense World
HilleVax (NASDAQ:HLVX) Stock Price Down 1.5% Following Weak Earnings - MarketBeat
HilleVax Reports Q3 Financial Results Amid Strategic Planning - TipRanks
HilleVax Inc. (HLVX) Quarterly 10-Q Report - Quartzy
Hillevax Inc (HLVX) 財務データ
収益
当期純利益
現金流量
EPS
Hillevax Inc (HLVX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| HERSHBERG ROBERT | See Remarks |
Feb 11 '25 |
Sale |
1.76 |
11,901 |
21,003 |
1,101,498 |
| Maltbie Shane | Chief Financial Officer |
Feb 11 '25 |
Sale |
1.76 |
4,345 |
7,659 |
79,887 |
| Maltbie Shane | Chief Financial Officer |
Feb 04 '25 |
Sale |
1.89 |
3,946 |
7,458 |
84,232 |
| Kohli Aditya | Director |
May 20 '24 |
Sale |
15.45 |
6,000 |
92,689 |
776,878 |
| Kohli Aditya | Director |
May 22 '24 |
Sale |
14.73 |
6,000 |
88,372 |
764,878 |
| Kohli Aditya | Director |
May 21 '24 |
Sale |
14.21 |
6,000 |
85,230 |
770,878 |
| Kohli Aditya | Director |
May 02 '24 |
Sale |
14.01 |
6,000 |
84,081 |
783,601 |
| Kohli Aditya | Director |
May 03 '24 |
Sale |
14.15 |
723 |
10,233 |
782,878 |
| Kohli Aditya | Director |
May 01 '24 |
Sale |
14.03 |
175 |
2,456 |
789,601 |
| Frazier Life Sciences X, L.P. | 10% Owner |
Apr 04 '24 |
Buy |
14.50 |
8,850 |
128,325 |
8,544,187 |
3.89%
0.13%
大文字化:
|
ボリューム (24 時間):